Introduction: In the pursuit of innovative cancer therapies, the intersection of immunotherapy and metabolic pathways has emerged as a promising frontier in oncology. Metabolic reprogramming is a hallmark of cancer, enabling tumor cells to sustain rapid proliferation and evade immune surveillance. Harnessing this metabolic plasticity to enhance immune responses and selectively target tumor cells represents a novel approach to cancer treatment. This blog explores the burgeoning field of targeted immunometabolic therapy, highlighting the intricate crosstalk between immune cells and metabolic pathways and its implications for cancer treatment.   Metabolic Reprogramming in Cancer: Cancer cells exhibit profound alterations in cellular metabolism…